live attenuated vaccine strain engineering

Eveliqure Biotechnologies is an innovative biotech company developing novel vaccines for the prevention of diarrhoeal diseases both for travellers and people living in endemic regions of low- and middle-income countries. It has developed a vaccine technology platform based on a live attenuated vaccine strain of the bacterium Shigella, engineered to induce broad protection against different species and serotypes, and expressing non-shigella derived antigens for protection against multiple pathogens. Its first-generation vaccine candidate, ShigETEC, target

Read more

antigen expressionvaccine development